Viewing Study NCT04201457

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-05 @ 3:40 PM
Study NCT ID: NCT04201457
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-04
First Post: 2019-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration
Sponsor: Pediatric Brain Tumor Consortium
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Low Grade Glioma (LGG) of Brain With BRAF Aberration View
None High Grade Glioma (HGG) of the Brain With BRAF Aberration View
None Low Grade Glioma of Brain With Neurofibromatosis Type 1 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HGG View
None BRAF View
None NF-1 View
None Autophagy View
None LGG View